Viewing Study NCT05679466


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-01-01 @ 12:52 PM
Study NCT ID: NCT05679466
Status: UNKNOWN
Last Update Posted: 2023-01-11
First Post: 2023-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older
Sponsor: Yu Qin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module